Skip to main content

Sangamo Therapeutics, Inc 10-K for FY2022

Sangamo Therapeutics, Inc (SGMOQ)

10-K 2023-02-23 For: 2022-12-31
View Original
Added on April 10, 2026

About this 10-K

Sangamo Therapeutics, Inc filed this 10-K on February 23, 2023, covering the fiscal year ended December 31, 2022 (FY2022).

Headline figures

Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$111.3M
up 0.5% from $110.7M a year earlier
Net loss
$192.28M
compared with a net loss of $178.29M a year earlier
Diluted EPS
-$1.25
compared with -$1.23 a year earlier